These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3559542)

  • 41. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat.
    Jones SR; Garris PA; Kilts CD; Wightman RM
    J Neurochem; 1995 Jun; 64(6):2581-9. PubMed ID: 7760038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
    Hyttel J; Larsen JJ
    J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of interaction of heavy metals on (Na+ -K+) ATPase and the uptake of 3H-DA and 3H-NA in rat brain synaptosomes.
    Chandra SV; Murthy RC; Husain T; Bansal SK
    Acta Pharmacol Toxicol (Copenh); 1984 Mar; 54(3):210-3. PubMed ID: 6326468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics.
    Memo M; Kleinman JE; Hanbauer I
    Science; 1983 Sep; 221(4617):1304-7. PubMed ID: 6310753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synaptosomal uptake and release of dopamine in rat striatum after hypoxia.
    Odarjuk J; Hetey L; Gross J
    J Neurochem; 1987 Apr; 48(4):1115-20. PubMed ID: 3819723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased brain dopamine and dopamine receptors in schizophrenia.
    Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
    Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biogenic monoamine uptake by rat brain synaptosomes during aging. Effects of nootropic drugs.
    Stancheva SL; Alova LG
    Gen Pharmacol; 1994 Sep; 25(5):981-7. PubMed ID: 7835648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
    Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
    Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
    Sundström E; Strömberg I; Tsutsumi T; Olson L; Jonsson G
    Brain Res; 1987 Mar; 405(1):26-38. PubMed ID: 2882814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses.
    Bird ED; Spokes EG; Barnes J; MacKay AV; Iversen LL; Shepherd M
    Lancet; 1977 Dec; 2(8049):1157-8. PubMed ID: 73064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chlordecone interaction with catecholamine binding and uptake in rat brain synaptosomes.
    Desaiah D
    Neurotoxicology; 1985; 6(1):159-65. PubMed ID: 2581192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional changes in monoamine content and uptake of the rat brain during postnatal development.
    Nomura Y; Naitoh F; Segawa T
    Brain Res; 1976 Jan; 101(2):305-15. PubMed ID: 1244975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
    Arnt J; Christensen AV; Hyttel J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):101-7. PubMed ID: 2409454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.
    Bird ED; Spokes EG; Iversen LL
    Acta Psychiatr Scand Suppl; 1980; 280():63-73. PubMed ID: 6447433
    [No Abstract]   [Full Text] [Related]  

  • 58. ATP-regulated neuronal catecholamine uptake: a new mechanism.
    Cao CJ; Eldefrawi AT; Eldefrawi ME
    Life Sci; 1990; 47(7):655-67. PubMed ID: 2402189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic abnormalities in postmortem schizophrenic brain.
    Mackay AV; Bird ED; Iversen LL; Spokes EG; Creese I; Snyder SH
    Adv Biochem Psychopharmacol; 1980; 24():325-33. PubMed ID: 7405668
    [No Abstract]   [Full Text] [Related]  

  • 60. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.